Bhilwade HN et al. |
Squalene as novel food factor. |
2010 |
Curr Pharm Biotechnol |
pmid:20874681
|
Iannitti T and Palmieri B |
An update on the therapeutic role of alkylglycerols. |
2010 |
Mar Drugs |
pmid:20948908
|
Fragapane E et al. |
A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. |
2010 |
Clin. Vaccine Immunol. |
pmid:20810680
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major. |
2010 |
Vaccine |
pmid:20888873
|
Khurana S et al. |
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. |
2010 |
Sci Transl Med |
pmid:20371470
|
Lippi G et al. |
Vaccination, squalene and anti-squalene antibodies: facts or fiction? |
2010 |
Eur. J. Intern. Med. |
pmid:20206873
|
Barnett SW et al. |
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. |
2010 |
J. Virol. |
pmid:20392857
|
Caron J et al. |
Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20363623
|
Xiong Z et al. |
A short total synthesis of (+)-omaezakianol via an epoxide-initiated cationic cascade reaction. |
2010 |
Org. Lett. |
pmid:20218639
|
Durando P et al. |
MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk. |
2010 |
Expert Opin Biol Ther |
pmid:20218923
|
Taramino S et al. |
Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast. |
2010 |
Biochim. Biophys. Acta |
pmid:19879375
|
van Himbergen TM et al. |
Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19834104
|
Keitel W et al. |
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. |
2010 |
Vaccine |
pmid:19835829
|
Brunner R et al. |
The ABC of clinical and experimental adjuvants--a brief overview. |
2010 |
Immunol. Lett. |
pmid:19895847
|
Eroglu E and Melis A |
Extracellular terpenoid hydrocarbon extraction and quantitation from the green microalgae Botryococcus braunii var. Showa. |
2010 |
Bioresour. Technol. |
pmid:20005092
|
Kalvodova L |
Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:20018176
|
Xiao L et al. |
The effect of squalane-dissolved fullerene-C60 on adipogenesis-accompanied oxidative stress and macrophage activation in a preadipocyte-monocyte co-culture system. |
2010 |
Biomaterials |
pmid:20488530
|
Carmona A et al. |
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. |
2010 |
Vaccine |
pmid:20600478
|
Caligiani A et al. |
Characterization of a potential nutraceutical ingredient: pomegranate (Punica granatum L.) seed oil unsaponifiable fraction. |
2010 |
Plant Foods Hum Nutr |
pmid:20607413
|
Zhao RY et al. |
Cloning and characterization of squalene synthase gene from Fusarium fujikuroi (Saw.) Wr. |
2010 |
J. Ind. Microbiol. Biotechnol. |
pmid:20585832
|
Yasuda Y et al. |
Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. |
2010 |
Adv Ther |
pmid:20586002
|
Frey SE et al. |
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. |
2010 |
Vaccine |
pmid:20619382
|
Dosio F et al. |
Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation. |
2010 |
Bioconjug. Chem. |
pmid:20597546
|
Sarpietro MG et al. |
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface. |
2010 |
Int J Pharm |
pmid:20635474
|
Wohlrab J et al. |
Interaction of epicutaneously applied lipids with stratum corneum depends on the presence of either emulsifiers or hydrogenated phosphatidylcholine. |
2010 |
Skin Pharmacol Physiol |
pmid:20523109
|
Koohang A et al. |
Enantioselective inhibition of squalene synthase by aziridine analogues of presqualene diphosphate. |
2010 |
J. Org. Chem. |
pmid:20545375
|
Camin F et al. |
Stable isotope ratios of carbon and hydrogen to distinguish olive oil from shark squalene-squalane. |
2010 |
Rapid Commun. Mass Spectrom. |
pmid:20499327
|
Mantzouridou F and Tsimidou MZ |
Observations on squalene accumulation in Saccharomyces cerevisiae due to the manipulation of HMG2 and ERG6. |
2010 |
FEMS Yeast Res. |
pmid:20550581
|
Van Damme P et al. |
Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. |
2010 |
BMC Infect. Dis. |
pmid:20504306
|
Waddington CS et al. |
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. |
2010 |
BMJ |
pmid:20508026
|
Beck F et al. |
Queries about vaccines containing squalene. |
2010 |
Immunol. Cell Biol. |
pmid:20157330
|
Gerpe A et al. |
Naftifine-analogues as anti-Trypanosoma cruzi agents. |
2010 |
Eur J Med Chem |
pmid:20163894
|
Warleta F et al. |
Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. |
2010 |
Food Chem. Toxicol. |
pmid:20138105
|
Sugihara N et al. |
Novel fractionation method for squalene and phytosterols contained in the deodorization distillate of rice bran oil. |
2010 |
J Oleo Sci |
pmid:20103978
|
Chen CC et al. |
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. |
2010 |
Eur J Pharm Biopharm |
pmid:20060469
|
Spanova M et al. |
Effect of lipid particle biogenesis on the subcellular distribution of squalene in the yeast Saccharomyces cerevisiae. |
2010 |
J. Biol. Chem. |
pmid:20032462
|
Tsai T et al. |
Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis. |
2010 |
Vaccine |
pmid:19969117
|
Narayan BH et al. |
Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice. |
2010 |
Food Funct |
pmid:21776469
|
Bildstein L et al. |
Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. |
2010 |
J Control Release |
pmid:20691740
|
Weiss TL et al. |
Raman spectroscopy analysis of botryococcene hydrocarbons from the green microalga Botryococcus braunii. |
2010 |
J. Biol. Chem. |
pmid:20705610
|
Kato S et al. |
Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. |
2010 |
J Nanosci Nanotechnol |
pmid:21137794
|
Lin FY et al. |
Mechanism of action and inhibition of dehydrosqualene synthase. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21098670
|
Ali NA et al. |
Essential oil composition of leaves of Stachys yemenensis obtained by supercritical COâ‚‚. |
2010 |
Nat. Prod. Res. |
pmid:21104527
|
Walker WT and Faust SN |
Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine. |
2010 |
Expert Rev Vaccines |
pmid:21105775
|
El Sahly H |
MF59™ as a vaccine adjuvant: a review of safety and immunogenicity. |
2010 |
Expert Rev Vaccines |
pmid:20923265
|
Waddington C et al. |
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. |
2010 |
Health Technol Assess |
pmid:20923610
|
Reddy LH et al. |
Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. |
2009 Sep-Oct |
Mol. Pharm. |
pmid:19634915
|
Huang MH et al. |
Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine. |
2009 May-Jun |
Microbes Infect. |
pmid:19344782
|
Kopena R et al. |
Lipophilic compounds from the femoral gland secretions of male Hungarian green lizards, Lacerta viridis. |
2009 May-Jun |
Z. Naturforsch., C, J. Biosci. |
pmid:19678551
|
Seiki S and Frishman WH |
Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. |
2009 Mar-Apr |
Cardiol Rev |
pmid:19367148
|
Huang ZR et al. |
Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. |
2009 |
Molecules |
pmid:19169201
|
Banzhoff A et al. |
MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. |
2009 |
PLoS ONE |
pmid:19197383
|
Tritto E et al. |
Mechanism of action of licensed vaccine adjuvants. |
2009 |
Vaccine |
pmid:19200813
|
Ansaldi F et al. |
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection. |
2009 |
Vaccine |
pmid:19200846
|
Galli G et al. |
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. |
2009 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:19237568
|
Lambrecht BN et al. |
Mechanism of action of clinically approved adjuvants. |
2009 |
Curr. Opin. Immunol. |
pmid:19246182
|
Morimoto Y et al. |
Total synthesis and determination of the absolute configuration of (+)-omaezakianol. |
2009 |
Angew. Chem. Int. Ed. Engl. |
pmid:19248063
|
Burke B et al. |
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits. |
2009 |
Virology |
pmid:19249806
|
Baudner BC et al. |
MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). |
2009 |
Pharm. Res. |
pmid:19255727
|
Radak BK et al. |
Modeling reactive scattering of F(2P) at a liquid squalane interface: a hybrid QM/MM molecular dynamics study. |
2009 |
J Phys Chem A |
pmid:19323516
|
Kato S et al. |
Biological safety of LipoFullerene composed of squalane and fullerene-C60 upon mutagenesis, photocytotoxicity, and permeability into the human skin tissue. |
2009 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19371265
|
Campagnac E et al. |
Fenpropimorph slows down the sterol pathway and the development of the arbuscular mycorrhizal fungus Glomus intraradices. |
2009 |
Mycorrhiza |
pmid:19340463
|
Cheng J and Hoshino T |
Cyclization cascade of the C33-bisnorheptaprenoid catalyzed by recombinant squalene cyclase. |
2009 |
Org. Biomol. Chem. |
pmid:19343258
|
Seelert H et al. |
From protons to OXPHOS supercomplexes and Alzheimer's disease: structure-dynamics-function relationships of energy-transducing membranes. |
2009 |
Biochim. Biophys. Acta |
pmid:19281792
|
Uchida H et al. |
Cloning and characterization of a squalene synthase gene from a petroleum plant, Euphorbia tirucalli L. |
2009 |
Planta |
pmid:19283408
|
Sarpietro MG et al. |
Conjugation of squalene to acyclovir improves the affinity for biomembrane models. |
2009 |
Int J Pharm |
pmid:19686827
|
Pellegrini M et al. |
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. |
2009 |
Vaccine |
pmid:19751689
|
Ryu A et al. |
Squalene as a target molecule in skin hyperpigmentation caused by singlet oxygen. |
2009 |
Biol. Pharm. Bull. |
pmid:19721223
|
Clark TW et al. |
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. |
2009 |
N. Engl. J. Med. |
pmid:19745215
|
Ghimire GP et al. |
Improved squalene production via modulation of the methylerythritol 4-phosphate pathway and heterologous expression of genes from Streptomyces peucetius ATCC 27952 in Escherichia coli. |
2009 |
Appl. Environ. Microbiol. |
pmid:19767465
|
Shabtay A et al. |
The potential of Pleurotus-treated olive mill solid waste as cattle feed. |
2009 |
Bioresour. Technol. |
pmid:19683915
|
Pedroso N et al. |
Modulation of plasma membrane lipid profile and microdomains by H2O2 in Saccharomyces cerevisiae. |
2009 |
Free Radic. Biol. Med. |
pmid:19027845
|
Laitinen K et al. |
Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety. |
2009 |
Br. J. Nutr. |
pmid:19017423
|
Godio RP and MartÃn JF |
Modified oxidosqualene cyclases in the formation of bioactive secondary metabolites: biosynthesis of the antitumor clavaric acid. |
2009 |
Fungal Genet. Biol. |
pmid:19130892
|
Wertz PW |
Human synthetic sebum formulation and stability under conditions of use and storage. |
2009 |
Int J Cosmet Sci |
pmid:19134124
|
Matyas GR et al. |
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. |
2009 |
Biochim. Biophys. Acta |
pmid:19100711
|
Ghimire GP et al. |
Squalene-hopene cyclase (Spterp25) from Streptomyces peucetius: sequence analysis, expression and functional characterization. |
2009 |
Biotechnol. Lett. |
pmid:19116691
|
Alam MM et al. |
Phase behavior, formation, and rheology of cubic phase and related gel emulsion in Tween 80/water/oil systems. |
2009 |
J Oleo Sci |
pmid:19491531
|
Herchi W et al. |
Characterization and quantification of the aliphatic hydrocarbon fraction during linseed development ( Linum usitatissimum L.). |
2009 |
J. Agric. Food Chem. |
pmid:19492811
|
Cho S et al. |
High-dose squalene ingestion increases type I procollagen and decreases ultraviolet-induced DNA damage in human skin in vivo but is associated with transient adverse effects. |
2009 |
Clin. Exp. Dermatol. |
pmid:19522983
|
Petrick L and Dubowski Y |
Heterogeneous oxidation of squalene film by ozone under various indoor conditions. |
2009 |
Indoor Air |
pmid:19500173
|
Tokuhiro K et al. |
Overproduction of geranylgeraniol by metabolically engineered Saccharomyces cerevisiae. |
2009 |
Appl. Environ. Microbiol. |
pmid:19592534
|
Pass RF |
Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. |
2009 |
J. Clin. Virol. |
pmid:19647480
|
Forrest HL et al. |
Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. |
2009 |
Vaccine |
pmid:19406182
|
López P and MartÃn J |
Potential chemosignals associated with male identity in the amphisbaenian Blanus cinereus. |
2009 |
Chem. Senses |
pmid:19406874
|
Al-Edresi S and Baie S |
Formulation and stability of whitening VCO-in-water nano-cream. |
2009 |
Int J Pharm |
pmid:19429303
|
Camilloni B et al. |
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. |
2009 |
Vaccine |
pmid:19410623
|
Galli G et al. |
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. |
2009 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:19416838
|
Phillips CJ et al. |
Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. |
2009 |
Vaccine |
pmid:19379786
|
Del Giudice G et al. |
Seasonal influenza vaccine provides priming for A/H1N1 immunization. |
2009 |
Sci Transl Med |
pmid:20371459
|
Couvreur P |
["Squalenoylation": a new approach to the design of anticancer and antiviral nanomedicines]. |
2009 |
Bull. Acad. Natl. Med. |
pmid:19883017
|
Tong R et al. |
Stereo- and regioselective synthesis of squalene tetraepoxide. |
2009 |
J. Org. Chem. |
pmid:19827774
|
Vesikari T et al. |
MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. |
2009 |
Vaccine |
pmid:19840662
|
Kim ES et al. |
Squalene-induced exogenous lipoid pneumonia in an infant. |
2009 |
Pediatr Int |
pmid:19799746
|
Laursen AB |
[Dangerous adjuvant in swine influenza vaccine]. |
2009 |
Ugeskr. Laeg. |
pmid:19866499
|
Reddy LH and Couvreur P |
Squalene: A natural triterpene for use in disease management and therapy. |
2009 |
Adv. Drug Deliv. Rev. |
pmid:19804806
|
Gerpe A et al. |
5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene. |
2009 |
Bioorg. Med. Chem. |
pmid:19811923
|
Bildstein L et al. |
Freeze-drying of squalenoylated nucleoside analogue nanoparticles. |
2009 |
Int J Pharm |
pmid:19782881
|
Fox CB |
Squalene emulsions for parenteral vaccine and drug delivery. |
2009 |
Molecules |
pmid:19783926
|
Leszczynska A et al. |
Investigating the effects of statins on cellular lipid metabolism using a yeast expression system. |
2009 |
PLoS ONE |
pmid:20041128
|